Plant ID: NPO22054
Plant Latin Name: Cinchona officinalis
Taxonomy Genus: Cinchona
Taxonomy Family: Rubiaceae
NCBI TaxonomyDB:
273781
Plant-of-the-World-Online:
n.a.
India
SMN1;SMN2; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0006706; steroid catabolic process | 5.222E-06 | 3.306E-02 | CYP19A1, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0008209; androgen metabolic process | 6.074E-06 | 3.306E-02 | CYP19A1, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 4.066E-06 | 3.306E-02 | CYP19A1, CYP3A4 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 1.590E-05 | 5.769E-02 | CYP19A1, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0042446; hormone biosynthetic process | 2.937E-05 | 9.136E-02 | CYP19A1, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006694; steroid biosynthetic process | 1.261E-04 | 1.989E-01 | CYP19A1, CYP3A4 |
MF | GO:0005488; binding | GO:0020037; heme binding | 1.301E-04 | 1.989E-01 | CYP19A1, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0009822; alkaloid catabolic process | 4.659E-04 | 3.498E-01 | CYP3A4 |
CC | GO:0016020; membrane | GO:0005789; endoplasmic reticulum membrane | 6.597E-03 | 1.000E+00 | CYP19A1, CYP3A4 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 2.475E-05 | 2.475E-04 | CYP3A4, CYP19A1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04913 | Ovarian steroidogenesis | 7.482E-03 | 1.225E-02 | CYP19A1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 4.344E-03 | 1.225E-02 | CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00983 | Drug metabolism - other enzymes | 6.884E-03 | 1.225E-02 | CYP3A4 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 1.103E-02 | 1.225E-02 | CYP3A4, CYP19A1 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 9.719E-03 | 1.225E-02 | CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.031E-02 | 1.225E-02 | CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.091E-02 | 1.225E-02 | CYP3A4 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 1.061E-02 | 1.225E-02 | CYP3A4 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 1.225E-02 | 1.225E-02 | CYP3A4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Anxiety disorder | F32, F40-F42 | CYP3A4; |